Location
Rutherford, NJ
Signature
/s/ Nelson Mullins Riley & Scarborough LLP, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John A. Ballantyne Revocable Living Trust dated 08/01/2017:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Glucotrack, Inc. 10%+ Owner Common Stock, par value $0.001 per share 2.74M $85.1M $31.00 12 Mar 2025 Direct
Glucotrack, Inc. 10%+ Owner Series A Common Warrant 132K 14 Nov 2024 Direct
Glucotrack, Inc. 10%+ Owner Warrants to Purchase Common Stock 59.3K 30 Jul 2024 Direct
Glucotrack, Inc. 10%+ Owner Series B Common Warrant 0 12 Mar 2025 Direct

Insider Reports Filed by John A. Ballantyne Revocable Living Trust dated 08/01/2017

Symbol Company Period Transactions Value $ Form Type Role Filing Time
GCTK Glucotrack, Inc. 30 Jul 2024 8 $4.09M 4 10%+ Owner 31 Mar 2025, 09:20
GCTK Glucotrack, Inc. 30 Jul 2024 0 $0 3 10%+ Owner 28 Mar 2025, 20:31